N-terminal pro-brain BNP (NT-proBNP) have been extensively studied for their predictive value in patients with heart failure. A systematic review now reveals that BNP is a strong prognostic ...
Elevated serum levels of cardiac troponin T (cTnT) and brain natriuretic peptide (BNP) are markers of poor outcome in patients with heart failure. To date, most studies of these markers have ...
Heart failure (HF) is a leading cause of morbidity and mortality worldwide. Testing for natriuretic peptide markers, such as B-type natriuretic peptide (BNP) or N-terminal proBNP (NT-proBNP), has ...
A natriuretic-peptide-guided approach to the management of HF was first tested in a pilot study of 69 patients in Christchurch, New Zealand by Troughton and colleagues. [41] In this study ...
Paid and presented by Boston Scientific. Sudden Cardiac Arrest (SCA) can happen without warning and in the absence of immediate medical assistance, can lead to death. Technological progress is now ...
Good afternoon, ladies and gentlemen, and welcome to the presentation of the BNP Paribas Third Quarter 2024 Results with Jean-Laurent Bonnafe, Group Chief Financial Officer; and Lars Machenil, Group ...